Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine Anti-platelet Effect After PCI
NCT03378934Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2018
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of berberine in coronary artery disease (CAD), sponsored by Peking Union Medical College Hospital. Started Sep 2018; status: recruiting.
02
Drugs
berberine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03378934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378934.